Showing posts with label European Collection of cell Cultures (ECACC). Show all posts
Showing posts with label European Collection of cell Cultures (ECACC). Show all posts

Wednesday 19 December 2018

Aerospace Coatings Market Expected To Trigger A Revenue Increase To USD 2.48 Billion By 2025:Key Participant Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc.


San Francisco, 20 December 2018,  Aerospace Coating Market Size, Share & Trends Analysis Report By Resin (Epoxy, PU), By Product, By Application (Exterior, Interior), By End User, By Industry Category, And Segment Forecasts, 2018 - 2025
The global aerospace coatings market size is projected to reach USD 2.48 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.0% during the forecast period. Increasing air passenger traffic is one of the key factors driving the aviation industry, which translates into greater demand for aerospace coatings.
Aerospace coatings offer aesthetic appeal and resistance towards corrosion, chemical, electrical and erosion. They are designed and formulated to obtain extended aircraft life. The growth of the aviation industry due to increasing per capita income and rising air cargo transports is expected to fuel the demand for the product. The demand for polyurethane resin is anticipated to be high throughout the forecast period as they hold very low VOC content and are chromate-free in nature.
North America was the largest market for aerospace coatings in 2017. It is poised to retain its position through 2025. The region is likely to register a healthy growth rate during the forecast period, owing to substantial demand from the U.S. Countries in Europe have been investing in manufacturing of commercial aircrafts, aiming to reduce imports of aircraft from the U.S. This, in turn, has resulted in considerable demand for these coatings in countries such as Germany, France, U.K., and Italy.
Surging demand for air travel from countries such as China and Japan is estimated to drive the market in Asia Pacific over the forecast years. Presence of various long airline routes in Asia Pacific is boosting the demand for aerospace coatings. Several government initiatives in countries such as encouraging private investments in the aerospace industry to allow domestic aerospace companies to compete globally are expected to foster the demand for aerospace coatings in Asia Pacific
Access Full Research Report On Aerospace Coatings Market Analysis:
www.grandviewresearch.com/industry-analysis/aerospace-coatings-market

Further key findings from the report suggest:
·         In terms of volume, the polyurethane resin segment is expected to witness steady growth of 5.4% over the forecast period, owing to increasing demand from commercial aviation OEMs
·         The liquid product segment dominated the global market in 2017, with a revenue share of 74.1%
·         In terms of volume, the military end-user segment is projected to witness the highest CAGR of 5.5% from 2018 to 2025
·         There will be a high demand for aerospace coating from the MRO industry in Asia Pacific, owing to surging demand in countries such as Singapore, China, and South Korea
·         The exterior application segment dominated the market, with a revenue share of over 70.0% in 2017, owing to its increased use in the commercial and military end-user segment
·         The U.S. aerospace coatings market is anticipated to exceed 9.72 kilotons by 2025, owing to increasing military spending and higher demand for passenger travel
·         The market has intense competition among key players owing to the fact that the products offered by manufacturers have low differentiation
·         Some of the key companies present in the market are AkzoNobel N.V; PPG Industries, Inc.; Sherwin-Williams; Hentzen Coatings, Inc.; and Mankiewicz Gebr. & Co; Axalta Coating Systems Ltd; Saint-Gobain S.A; Henkel Corporation; IHI Ionbond AG; Zircotec Ltd; LORD Corporation; AHC Oberflächentechnik; BryCoat Inc.; and NV Specialty Coatings.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry-analysis/aerospace-coatings-market
Grand View Research has segmented the global aerospace coatings market on the basis of resin, product, end user, industry category, application, and region.
Resin Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Epoxy
·         Polyurethane
·         Others
Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Liquid
·         Powder
End User Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Commercial
·         Military
·         Others
Industry Category Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         OEM
·         MRO
Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Exterior
·         Interior
Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S
·         Europe
o    Germany
o    U.K.
o    France
o    Italy
·         Asia Pacific
o    China
o    Japan
·         Central & South America
o    Brazil
·         Middle East & Africa 


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Cell Line Development Market Expected To Trigger A Revenue Increase To USD 6.24 Billion By 2022:Key Participant Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc.

San Francisco, 19 December 2018, Cell Line Development Market Size, Share & Trends Analysis Report by Product, By Source (Mammalian, Non-Mammalian), By Type of Cells, By Application, By Technology, And Segment Forecasts, 2012 – 2022
Global cellline development market size is expected to reach USD 6.24 billion by 2022, according to a new report by Grand View Research, Inc. The Increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period.
Increasing prevalence of autoimmune diseases and cancer are likely to increase the demand for accurate and cost effective treatment options which is expected to render a positive impact on market growth. In addition, improving healthcare infrastructure, economic development and favorable government initiatives promoting the growth of the biotechnology industry are factors contributing towards the growth of the cell line development market.
Ongoing R&D for stable & authentic cell lines and the introduction of technologically advanced processes such as single use bioreactor and micro bioreactor for large scale bioproduction are further expected to provide this market with lucrative future growth opportunities.
Access Full Research Report On Cell Line Development Market  Analysis:

Further key findings from the study suggest:
·         Reagent and media was the largest product market in 2014, owing to increasing number of cell culture procedures. Reagent and media are necessary components involved in cell line development procedures & cell culture and are cost intensive in nature. The market for reagent and media was valued at over 1.0 billion in 2014.
·         Mammalian cell lines were widely used as a source for cell line development in 2014, owing to associated advantages such as accurate complex protein expression nature, critical for the production of monoclonal antibodies, vaccines, and biologics.
·         Cell line development finds the largest application in the bioproduction of biologics, vaccines, Mabs, therapeutic proteins and biosimilars. Rising demand for monoclonal antibodies and vaccines are expected to boost the growth of this segment over the forecast period. The market for cell line development based bioproduction is also expected to witness lucrative growth of over 12.5% during the forecast period.
·         North America was the largest market in 2014, with revenue estimated at over 800 million. The region’s market dominance is attributed to factors such as the growing adoption rates of cell culture techniques, presence of well developed healthcare infrastructure, supportive government initiatives and high healthcare expenditure levels.
·         Asia Pacific cell line development market is anticipated to register rapid growth over the forecast period owing to factors such as the presence of high unmet needs, rising number of CROs (Contract Research Organization) providing pertinent services, growing R&D investments aimed at the development of stable cell lines and increasing biologics production.
·         Key players in this market include European Collection of cell Cultures (ECACC), Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc., Sartorious AG, Selexis SA, Wuxi AppTec Inc., Sigma-Aldrich Corporation, American Type Culture Collection (ATCC) and Corning Inc. 
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global cell line development market on the basis of product, source, type of cell line, application and region:
Global Cell Line Development Product Outlook (Revenue, USD Million, 2012 - 2022)
o    Reagents and media
o    Equipment Accessories and consumables
o    Incubators
o    Centrifuges
o    Bioreactors
o    Storage equipment
o    Microscopes
Global Cell Line Development Source Outlook (Revenue, USD Million, 2012 - 2022)
o    Mammalian
o    Non mammalian
o    Insects
o    Amphibians
Global Cell Line Development Type Of Cell Line Outlook (Revenue, USD Million, 2012 - 2022)
o    Recombinant cell lines
o    Hybridomas
o    Continuous cell line
o    Primary cell lines
Global Cell Line Development Application Outlook (Revenue, USD Million, 2012 - 2022)
o    Bioproduction
o    Drug discovery
o    Toxicity testing
o    Tissue engineering
o    Research
Cell Line Development Regional Outlook (Revenue, USD Billion, 2014 - 2022)
o    North America
o    U.S.
o    Canada
o    Europe
o    Germany
o    UK
o    Asia Pacific
o    China
o    Japan
o    India
o    Latin America
o    Mexico
o    Brazil
o    MEA
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/